Webb27 apr. 2024 · Cisplatin is an inorganic complex and a widely used anticancer drug in … WebbEver since the initial discovery of the anticancer activity of cisplatin, major efforts have been devoted to elucidate the biochemical mechanisms of antitumor activity of cisplatin in order to be able to rationally design novel platinum based drugs with superior pharmacological profiles.
Ruthenium and iridium based mononuclear and ... - ScienceDirect
WebbAbstract. Platinum (Pt) compounds entered the clinic as anticancer agents when … WebbIn this work, two thiourea ligands bearing a phosphine group in one arm and in the other a phenyl group (T2) or 3,5-di-CF3 substituted phenyl ring (T1) have been prepared and their coordination to Au and Ag has been studied. A different behavior is observed for gold complexes, a linear geometry with coordination only to the phosphorus atom or an … how to milk the male prostate
Determination of IC50 values of anticancer drugs on cells by D2O ...
WebbAmong the platinum-based anticancer drugs, Cisplatin (cis-diamine dichloroplatinum (II), cis- [Pt (NH3)2Cl2]) is one of the most potent components of cancer chemotherapy. The nephrotoxicity, neurotoxicity and ototoxicity, and platinum compounds associated resistant cancer are some major disadvantages. Webb10 mars 2015 · The history of cisplatin starts not in 1965, but in 1844, when it was first … The compound cis-[Pt(NH3)2Cl2] was first described by Italian chemist Michele Peyrone in 1845, and known for a long time as Peyrone's salt. The structure was deduced by Alfred Werner in 1893. In 1965, Barnett Rosenberg, Van Camp et al. of Michigan State University discovered that electrolysis of platinum electrodes generated a soluble platinum complex which inhibited binary fission in Escherichia coli (E. coli) bacteria. Although bacterial cell growth continued, cell division … multiplication sheets 4th grade